A detailed history of Penserra Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Penserra Capital Management LLC holds 51 shares of EW stock, worth $3,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 48 6.25%
Holding current value
$3,769
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $179 - $281
3 Added 6.25%
51 $3,000
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $199,992 - $263,458
-2,757 Reduced 98.29%
48 $4,000
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $37,087 - $46,733
-601 Reduced 17.65%
2,805 $213,000
Q3 2023

Nov 15, 2023

SELL
$69.28 - $93.38 $36,233 - $48,837
-523 Reduced 13.31%
3,406 $235,000
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $317,091 - $367,415
3,895 Added 11455.88%
3,929 $370,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $2,322 - $2,972
34 New
34 $2,000
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $69,682 - $88,675
-972 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $65,308 - $84,991
972 New
972 $77,000
Q2 2020

Aug 14, 2020

SELL
$57.54 - $76.95 $1.57 Million - $2.1 Million
-27,268 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $1.43 Million - $2.21 Million
27,268 New
27,268 $5.14 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $3.55 Million - $4.06 Million
-49,463 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$61.55 - $75.43 $3.04 Million - $3.73 Million
49,463 New
49,463 $10.9 Million
Q1 2019

May 08, 2019

SELL
$47.89 - $64.05 $2.31 Million - $3.09 Million
-48,292 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $2.1 Million - $2.58 Million
45,348 Added 1540.35%
48,292 $7.4 Million
Q3 2018

Nov 05, 2018

BUY
$45.7 - $58.03 $19,011 - $24,140
416 Added 16.46%
2,944 $512,000
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $541,874 - $654,844
-12,765 Reduced 83.47%
2,528 $368,000
Q1 2018

May 08, 2018

BUY
$37.19 - $47.45 $485,441 - $619,364
13,053 Added 582.72%
15,293 $2.13 Million
Q4 2017

Feb 07, 2018

BUY
$33.79 - $39.39 $11,894 - $13,865
352 Added 18.64%
2,240 $252,000
Q3 2017

Oct 26, 2017

BUY
$36.29 - $38.83 $8,128 - $8,697
224 Added 13.46%
1,888 $207,000
Q2 2017

Aug 21, 2017

BUY
N/A
1,664
1,664 $196,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.